Imaging of vasculitis: State of the art

Best Practice and Research: Clinical Rheumatology

Volumn 30, Issue 4, 2016, Pages 688-706

  Muratore, Francesco ^a   Pipitone, Nicolò ^a   Salvarani, Carlo ^a   Schmidt, Wolfgang A ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Color duplex ultrasonography; Computed tomography; Imaging; Magnetic resonance imaging; Positron emission tomography; Ultrasound; Vasculitis

Indexed keywords

AORTA ARCH SYNDROME; CARDIAC IMAGING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; ECHOGRAPHY; GIANT CELL ARTERITIS; HUMAN; LARGE VESSEL VASCULITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY; VASCULITIS; DIAGNOSTIC IMAGING; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; VASCULITIS;

EID: 85001090527     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2016.09.010     Document Type: Review

References (101)

1. Pipitone, N., Versari, A., Salvarani, C., Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 47 (2008), 403–408.
2. [2] Prieto-González, S., Arguis, P., Cid, M.C., Imaging in systemic vasculitis. Curr Opin Rheumatol 27 (2015), 53–62.
3. [3] Pipitone, N., Versari, A., Hunder, G.G., Salvarani, C., Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am 39 (2013), 593–608.
4. [4] Schmidt, W.A., Kraft, H.E., Vorpahl, K., et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337 (1997), 1336–1342.
5. [5] Schmidt, W.A., Imaging in vasculitis. Best Pract Res Clin Rheumatol 27 (2013), 107–118.
6. Patil, P., Williams, M., Maw, W.W., et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol, 33(2 Suppl. 89), 2015 S-103-106.
7. [7] Diamantopoulos, A.P., Haugeberg, G., Lindland, A., Myklebust, G., The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?. Rheumatology (Oxford) 55 (2016), 66–70.
8. [8] Schmidt, W.A., Ultrasound in vasculitis. Clin Exp Rheumatol 32:1 Suppl. 80 (2014), S71–S77.
9. [9] Schmidt, W.A., Role of ultrasound in the understanding and management of vasculitis. Ther Adv Rheum Dis 6 (2014), 39–47.
10. [10] Luqmani, R., Lee, E., Singh, S., et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis: a diagnostic accuracy and cost-effectiveness study. Arthritis Rheumatol 67:Suppl. 10 (2015), S2592–S2594.
11. [11] Karassa, F.B., Matsagas, M.I., Schmidt, W.A., Ioannidis, J.P., Diagnostic performance of ultrasonography for giant-cell arteritis: a meta-analysis. Ann Intern Med 142 (2005), 359–369.
12. [12] Luqmani, R., Lee, E., Singh, S., et al. Inter-Rater analysis of ultrasound and histological findings in patients with suspected giant cell arteritis. Arthritis Rheumatol 67:Suppl.10 (2015), S2336–S2337.
13. [13] Schmidt, W.A., Seifert, A., Gromnica-Ihle, E., et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47 (2008), 96–101.
14. [14] Muratore, F., Boiardi, L., Restuccia, G., et al. Comparison between colour duplex sonography findings and different histological patterns of temporal artery. Rheumatology (Oxford) 52 (2013), 2268–2274.
15. [15] Schäfer, V.S., Juche, A., Ramiro, S., et al. Cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Ann Rheum Dis, 75, 2016 (Suppl; Abstract FRI0393).
16. Aschwanden, M., Daikeler, T., Kesten, F., et al. Temporal artery compression sign - a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med 34 (2013), 47–50.
17. [17] Aschwanden, M., Imfeld, S., Staub, D., et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol 33:2 Suppl. 89 (2015), S113–S115.
18. [18] Germanò, G., Muratore, F., Cimino, L., et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology (Oxford) 54 (2015), 400–404.
19. [19] Hauenstein, C., Reinhard, M., Geiger, J., et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford) 51 (2012), 1999–2003.
20. [20] Diamantopoulos, A.P., Myklebust, G., Long-term inflammation in the temporal artery of a giant cell arteritis patient as detected by ultrasound. Ther Adv Musculoskelet Dis 6 (2014), 102–103.
21. [21] Muratore, F., Kermani, T.A., Crowson, C.S., et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology (Oxford) 54 (2015), 463–470.
22. [22] Czihal, M., Piller, A., Schroettle, A., et al. Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis. J Vasc Surg 61 (2015), 1285–1291.
23. [23] Czihal, M., Zanker, S., Rademacher, A., et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol 41 (2012), 231–236.
24. [24] Diamantopoulos, A.P., Haugeberg, G., Hetland, H., et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res (Hoboken) 66 (2014), 113–119.
25. [25] Schinkel, A.F., van den Oord, S.C., van der Steen, A.F., et al. Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging 15 (2014), 541–546.
26. Germanò, G., Macchioni, P., Possemato, N., et al. Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: correlation with positron emission tomography findings. Arthritis Care Res (Hoboken), 2016 Apr 5 [Epub ahead of print].
27. [27] Dasgupta, B., Cimmino, M.A., Maradit-Kremers, H., et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71 (2012), 484–492.
28. Macchioni, P., Boiardi, L., Catanoso, M., et al. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis 73 (2014), 1190–1193.
29. [29] Fan, W., Zhu, J., Li, J., et al. Ultrasound morphological changes in the carotid wall of Takayasu's arteritis: monitor of disease progression. Int Angiol 35 (2016), 586–592.
30. [30] Kilic, I.D., Di Mario, C., Atherosclerotic changes in coronary aneurysms post-Kawasaki disease: in vivo demonstration with near-infrared spectroscopy and intravascular ultrasound. Eur Heart J, 35, 2014, 2506.
31. [31] Brown, L.M., Duffy, C.E., Mitchell, C., Young, L., A practical guide to pediatric coronary artery imaging with echocardiography. J Am Soc Echocardiogr 28 (2015), 379–391.
32. [32] Wang, H., Li, J., Jiang, Y., et al. Polyarteritis nodosa with multiple aneurysms and renal arteriovenous fistula successfully diagnosed by colour Doppler sonography. Clin Rheumatol 32:Suppl. 1 (2013), S89–S92.
33. [33] Seyahi, E., Cakmak, O.S., Tutar, B., et al. Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome: an observational study. Medicine (Baltimore), 94, 2015, e1899.
34. [34] Alibaz-Oner, F., Karatay, E., Akpinar, I.N., et al. Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis. Clin Rheumatol 33 (2014), 277–280.
35. [35] Alberts, M., Temporal arteritis: improving patient evaluation with a new protocol. Perm J 17 (2013), 56–62.
36. [36] Chung, J.W., Kim, H.C., Choi, Y.H., et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45 (2007), 906–914.
37. [37] Yamada, I., Nakagawa, T., Himeno, Y., et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 209 (1998), 103–109.
38. Kang, E.J., Kim, S.M., Choe, Y.H., et al. Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology 270 (2014), 74–81.
39. [39] Paul, J.F., Fiessinger, J.N., Sapoval, M., et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr 25 (2001), 924–931.
40. [40] Yoshida, S., Akiba, H., Tamakawa, M., et al. The spectrum of findings in supra-aortic Takayasu's arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Interv Radiol 24 (2001), 117–121.
41. [41] Muratore, F., Pazzola, G., Pipitone, N., et al. Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 32 (2014), S106–S111.
42. Prieto-González, S., Arguis, P., García-Martínez, A., et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 71 (2012), 1170–1176.
43. [43] Prieto-González, S., García-Martínez, A., Tavera-Bahillo, I., et al. Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study. Medicine (Baltimore), 94, 2015, e486.
44. [44] García-Martínez, A., Hernández-Rodríguez, J., Arguis, P., et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 59 (2008), 422–430.
45. [45] García-Martínez, A., Arguis, P., Prieto-González, S., et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis 73 (2014), 1826–1832.
46. [46] Vaglio, A., Salvarani, C., Buzio, C., Retroperitoneal fibrosis. Lancet 367 (2006), 241–251.
47. [47] Calamia, K.T., Schirmer, M., Melikoglu, M., Major vessel involvement in Behçet's disease: an update. Curr Opin Rheumatol 23 (2011), 24–31.
48. [48] Düzgün, N., Ateş, A., Aydintuğ, O.T., et al. Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 35 (2006), 65–68.
49. [49] Erkan, F., Pulmonary involvement in Behçet disease. Curr Opin Pulm Med 5 (1999), 314–318.
50. [50] Lohrmann, C., Uhl, M., Kotter, E., et al. Pulmonary manifestations of wegener granulomatosis: CT findings in 57 patients and a review of the literature. Eur J Radiol 53 (2005), 471–477.
51. [51] Choi, Y.H., Im, J.G., Han, B.K., et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 117 (2000), 117–124.
52. [52] Lauque, D., Cadranel, J., Lazor, R., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Medicine (Baltimore) 79 (2000), 222–233.
53. [53] Yamagata, M., Ikeda, K., Tsushima, K., et al. Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients. Arthritis Rheumatol 68 (2016), 713–723.
54. [54] Yamada, I., Nakagawa, T., Himeno, Y., et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging 11 (2000), 481–487.
55. [55] Tso, E., Flamm, S.D., White, R.D., et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46 (2002), 1634–1642.
56. [56] Papa, M., De Cobelli, F., Baldissera, E., et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 198 (2012), W279–W284.
57. [57] Comarmond, C., Cluzel, P., Toledano, D., et al. Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. Am J Cardiol 113 (2014), 881–887.
58. [58] Ghinoi, A., Zuccoli, G., Nicolini, A., et al. 1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries. Clin Exp Rheumatol 26 (2008), S76–S80.
59. [59] Klink, T., Geiger, J., Both, M., et al. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology 273 (2014), 844–852.
60. [60] Veldhoen, S., Klink, T., Geiger, J., et al. MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis. Eur Radiol 24 (2014), 2971–2979.
61. [61] Siemonsen, S., Brekenfeld, C., Holst, B., et al. 3T MRI reveals extra- and intracranial involvement in giant cell arteritis. AJNR Am J Neuroradiol 36 (2015), 91–97.
62. [62] Muratore, F., Pazzola, G., Pipitone, N., Salvarani, C., Recent advances in the diagnosis and treatment of polymyalgia rheumatica. Expert Rev Clin Immunol 6 (2016), 1–9 [Epub ahead of print].
63. [63] Cantini, F., Salvarani, C., Olivieri, I., et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 28 (2001), 1049–1055.
64. [64] McGonagle, D., Pease, C., Marzo-Ortega, H., et al. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 28 (2001), 1837–1841.
65. [65] Cantini, F., Salvarani, C., Niccoli, L., et al. Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumatica. J Rheumatol 31 (2004), 120–124.
66. [66] Salvarani, C., Barozzi, L., Cantini, F., et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 67 (2008), 758–761.
67. [67] Salvarani, C., Barozzi, L., Boiardi, L., et al. Lumbar interspinous bursitis in active polymyalgia rheumatica. Clin Exp Rheumatol 31 (2013), 526–531.
68. [68] Salvarani, C., Brown, R.D. Jr., Hunder, G.G., Adult primary central nervous system vasculitis. Lancet 380 (2012), 767–777.
69. Salvarani, C., Brown, R.D. Jr., Christianson, T., et al. An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore), 94, 2015, e738.
70. [70] Salvarani, C., Brown, R.D. Jr., Huston, J. 3rd, Hunder, G.G., Prominent perivascular enhancement in primary central nervous system vasculitis. Clin Exp Rheumatol, 26(3 Suppl. 49), 2008, S111.
71. [71] Zuccoli, G., Pipitone, N., Haldipur, A., et al. Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol 29:1 Suppl. 64 (2011), S104–S109.
72. [72] Mandell, D.M., Matouk, C.C., Farb, R.I., et al. Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results. Stroke 43 (2012), 860–862.
73. [73] Obusez, E.C., Hui, F., Hajj-Ali, R.A., et al. High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. Am J Neuroradiol 35 (2014), 1527–1532.
74. [74] Stanson, A.W., Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 18 (2000), S43–S48.
75. [75] Stanson, A.W., Friese, J.L., Johnson, C.M., et al. Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 21 (2001), 151–159.
76. [76] Salvarani, C., Brown, R.D. Jr., Hunder, G.G., Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 24 (2012), 46–52.
77. Besson, F.L., Parienti, J.J., Bienvenu, B., et al. Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 38 (2011), 1764–1772.
78. [78] Brodmann, M., Lipp, R.W., Passath, A., et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43 (2004), 241–242.
79. [79] Meller, J., Strutz, F., Siefker, U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30 (2003), 730–736.
80. [80] Lensen, K.D., Comans, E.F., Voskuyl, A.E., et al. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT. Biomed Res Int, 2015, 2015, 914692.
81. [81] Belhocine, T., Blockmans, D., Hustinx, R., et al. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30 (2003), 1305–1313.
82. [82] Blockmans, D., Bley, T., Schmidt, W., Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21 (2009), 19–28.
83. [83] Germano, G., Versari, A., Muratore, F., et al. Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 29 (2011), S138–S139.
84. [84] Fuchs, M., Briel, M., Daikeler, T., et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 39 (2012), 344–353.
85. [85] Treglia, G., Mattoli, M.V., Leccisotti, L., et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 30 (2011), 1265–1275.
86. [86] Soussan, M., Nicolas, P., Schramm, C., et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore), 94, 2015, e622.
87. [87] Schafer, V.S., Warrington, K.J., Williamson, E.E., Kermani, T.A., Delayed diagnosis of biopsy-negative giant cell arteritis presenting as fever of unknown origin. J Gen Intern Med 24 (2009), 532–536.
88. [88] Blockmans, D., De Ceuninck, L., Vanderschueren, S., et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55 (2006), 131–137.
89. [89] Blockmans, D., Coudyzer, W., Vanderschueren, S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 47 (2008), 1179–1184.
90. [90] Iwabu, M., Yamamoto, Y., Dobashi, H., et al. F-18 FDG PET findings of Takayasu arteritis before and after immunosuppressive therapy. Clin Nucl Med 33 (2008), 872–873.
91. [91] Henes, J.C., Mueller, M., Pfannenberg, C., et al. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol 29 (2011), S43–S48.
92. [92] de Leeuw, K., Bijl, M., Jager, P.L., Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 22 (2004), S21–S26.
93. [93] Clifford, A., Burrell, S., Hanly, J.G., Positron emission tomography/computed tomography for the diagnosis and assessment of giant cell arteritis: when to consider it and why. J Rheumatol 39 (2012), 1909–1911.
94. [94] Arnaud, L., Haroche, J., Malek, Z., et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?. Arthritis Rheum 60 (2009), 1193–1200.
95. [95] Cheng, Y., Lv, N., Wang, Z., et al. 18-FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis. Clin Exp Rheumatol 31 (2013), S22–S27.
96. [96] Karapolat, I., Kalfa, M., Keser, G., et al. Comparison of F18-FDG PET/CT findings with current clinical disease status in patients with Takayasu's arteritis. Clin Exp Rheumatol 31 (2013), S15–S21.
97. [97] Magnani, L., Versari, A., Salvo, D., et al. Disease activity assessment in large vessel vasculitis. Reumatismo 63 (2011), 86–90.
98. [98] Balink, H., Houtman, P.M., Collins, J., 18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis. Clin Rheumatol 30 (2011), 1139–1141.
99. Salvarani, C., Pipitone, N., Versari, A., et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 53 (2005), 298–303.
100. [100] Vaglio, A., Greco, P., Versari, A., et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent “scar” ? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 23 (2005), 231–234.
101. [101] Bleeker-Rovers, C.P., Bredie, S.J., van der Meer, J.W., et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61 (2003), 323–329.